規制動向

FDA、EMA、TGA および世界の規制動向

#Ibandronate Sodium ×

2026年9月4日•1分で読めます

FDA Approves ANDA078948 for Ibandronate Sodium Tablet

The FDA has approved ANDA078948 for a prescription oral tablet of Ibandronate Sodium 150 mg, sponsored by Apotex and manufactured by Golden State Medical Supply.